ICON (ICLR) revenue

Revenue · fiscal 2025
$8.25B

ICON (ICLR) reported revenue of $8.25B in fiscal 2025 (the year ended December 31, 2025). That is 0.8% higher than the $8.19B of fiscal 2024. Figures as of 18 Nov 2026, 09:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$8.25B
Change on fiscal 2024
+0.8%
Growth, 5 years
+24.2% a year
Growth, 10 years
+18.0% a year
Highest on record
$8.25Bfiscal 2025
Lowest on record
$865.25Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ICON revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 24.2% a year; over ten years the rate was 18.0% a year. Across the 18 fiscal years on record (2008–2025), the highest was $8.25B in fiscal 2025 and the lowest $865.25M in fiscal 2008.

History · 18 fiscal years

Revenue by fiscal year

ICON revenue, year by year

ICON (ICLR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$8.25B 0.8% up
2024$8.19B 1.7% up
2023$8.05B 4.1% up
2022$7.74B 41.2% up
2021$5.48B 95.9% up
2020$2.80B 0.3% down
2019$2.81B 8.1% up
2018$2.60B 47.6% up
2017$1.76B 5.5% up
2016$1.67B 5.8% up
2015$1.57B 4.8% up
2014$1.50B 12.5% up
2013$1.34B 19.8% up
2012$1.12B 17.9% up
2011$945.73M 5.1% up
2010$900.04M 1.4% up
2009$887.61M 2.6% up
2008$865.25M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of ICON and comparable companies
CompanyRevenueFiscal year
Neurocrine Biosciences NBIX$2.86B2025
Ascendis Pharma ASND€720.13M2025
ICON ICLR$8.25B2025
Jazz Pharmaceuticals JAZZ$4.27B2025
Solventum SOLV$8.33B2025
BridgeBio Pharma BBIO$502.08M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ICLR

ICON, figure by figure

ICON (ICLR) overview: price, valuation and scorecardAll health care companies by market value

ICON revenue: questions and answers

What is ICON's revenue?

ICON (ICLR) reported revenue of $8.25B in fiscal 2025 (the year ended December 31, 2025). That is 0.8% higher than the $8.19B of fiscal 2024.

What is the growth rate of ICON's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 24.2% a year; over ten years the rate was 18.0% a year.

What are the highest and lowest revenue figures on record for ICON?

Across the 18 fiscal years on record (2008–2025), the highest was $8.25B in fiscal 2025 and the lowest $865.25M in fiscal 2008.

How is ICON's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For ICON it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ICON (ICLR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ICLR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.